Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 14, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, April 14, 2025 -- For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after neoadjuvant chemotherapy (NAC), with progression of chemotherapy leading to expanded abnormalities, according to a study published online April 9 in the Journal of Magnetic Resonance Imaging.

Jing Yang, from the Chongqing University Cancer Hospital in China, and colleagues examined changes in the brain connectome of patients with breast cancer at several time points during NAC in a longitudinal study. Fifty-five patients with breast cancer underwent clinical assessments and functional magnetic resonance imaging at baseline (TP1), the first cycle of NAC (TP2; 30 days later), and the end (TP3; 140 days later). The same assessments were also performed on two matched female healthy control groups (20 and 18 participants).

The researchers found that patients with breast cancer showed increased global efficiency post-NAC (TP2-TP1 = 0.087; TP3-TP1 = 0.078), decreased characteristic path length (TP2-TP1 = −0.413; TP3-TP1= −0.312), and altered nodal centralities mainly in the frontal-limbic system and cerebellar cortex. With chemotherapy progression, these abnormalities expanded significantly (TP2 versus TP3). There was also a correlation seen for topological parameter changes with clinical scale changes. There were no differences within or between healthy control groups or for breast cancer subgroups at TP1.

"The brain functional network in breast cancer patients after NAC showed a shift toward a more randomized pattern compared with that in breast cancer patients at baseline," the authors write. "The observed pattern of functional network connectivity alterations can more sensitively capture abnormalities in cognitive function and emotional processing in breast cancer patients after NAC."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-15 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords